DAK HEALTH has floated a tender for Completion of a Non -exclusive Discount Agreement According to Section 130a (8) Sgb V on the Active Ingredient Ranibizumab, Atc S01la04 for the Time 01.09.2022 - 31.08.2023 (plus Extension Option 1x12 Months). The project location is Germany and the tender is closing on 05 Jul 2024. The tender notice number is -, while the TOT Ref Number is 69242187. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Completion of a Non -exclusive Discount Agreement According to Section 130a (8) Sgb V on the Active Ingredient Ranibizumab, Atc S01la04 for the Time 01.09.2022 - 31.08.2023 (plus Extension Option 1x12 Months)

Deadline : 05 Jul 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 69242187

Document Ref. No. : xxxxxxxxx

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : EUR 1.00

Purchaser's Detail

Name :xxxxxxxxx

Address : xxxxxxxxx

Email : xxxxxxxxx

Login to see details

Documents

 Tender Notice